Drug Pipeline & Clinical Trials at NEI Fall Congress 2026
6 sessions on drug pipeline & clinical trials · November 5–8, 2026, Colorado Springs, CO. Compare drug pipeline & clinical trials at other meetings →
Thursday, November 5
14:25–15:10 · Lecture
The Mania Event: Unmet Needs, Treatment Challenges, and Emerging Pharmacotherapies in Bipolar Disorder
Roger S. McIntyre · Andrew J. Cutler
Examines unmet needs in treating acute mania, including mixed features, and evaluates emerging therapies such as recent lumateperone phase 3 data. Uses cases to illustrate individualized decisions.
Friday, November 6
12:30–13:30 · Session · Industry Session
Lunch Industry Session†: Learn about a psychiatric medicine with two FDA-approved uses
Industry-sponsored lunch session on a psychiatric medicine with two FDA-approved indications.
15:20–16:05 · Session · Industry Session
Afternoon Industry Session†: Treating Excessive Daytime Sleepiness due to OSA: Translating Clinical Trial Endpoints Into Practice
Industry-sponsored session on treating excessive daytime sleepiness due to obstructive sleep apnea and applying trial endpoints in practice.
18:45–19:45 · Session · Industry Session
Dinner Industry Session†: Inspired by Patients, Driven by Science: The Neurocrine Story
Dimitri E. Grigoriadis · Christopher F. O’Brien
Industry-sponsored dinner session on the company's research and development story.
Sunday, November 8
08:15–09:15 · Lecture
From Breakthrough to Scrutiny: Promise, Proof, and the Path to Practice for Psychedelic Therapeutics
Critical appraisal of the evidence for psychedelic therapies including psilocybin and MDMA, with attention to trial design pitfalls and practical readiness for clinical implementation.
Psychedelics · PTSD & Trauma · Treatment-Resistant Depression
11:30–12:30 · Panel
The Dating Game: Swipe Right on Psychopharmacology and Meet the Mystery Bachelor Meds
Christoph U. Correll · Roger S. McIntyre · Hara E. Oyedeji · Thomas L. Schwartz
Game-style interactive session in which faculty present psychiatric medications for audience guessing and discussion.
Other topics at this meeting
Depression 10Child & Adolescent 9Schizophrenia & Psychosis 8Neuroscience & Mechanisms 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Tardive Dyskinesia & Movement Disorders 6Long-Acting Injectables 4Treatment-Resistant Depression 4Antipsychotic Prescribing 3Psychedelics 3